Krishna Institute of Medical Sciences Share Price

    NSE
    769.65
    +0.50 (0.00%)
    KIMS • 20 Aug, 2025 | 11:11 AM
    Buy
    with MTF at2.86xleverage

    1Y Annualised Return

    60.49%

    3Y Annualised Return

    47.33%

    The current prices are delayed, login or Open Demat Account for live prices.

    Krishna Institute of Medical Sciences Stock Performance

    1W Return5.28
    1Y Return62.19
    Today's Low765
    Prev. Close769.15
    Mkt Cap (Cr.)30,776.69
    1M Return1.12
    3Y Return215.67
    52-Week High798.4
    Open770.95
    PE Ratio105.12
    6M Return42.03
    Today's High773
    52-Week Low461.63
    Face Value2

    Krishna Institute of Medical Sciences Company background

    Founded in: 1973
    Managing director: Bhaskara Rao Bollineni
    Krishna Institute of Medical Sciences Limited (KIMS) was erstwhile incorporated as Jagjit Singh and Sons Private Limited, a Private Limited Company on July 26, 1973 in Mumbai. Subsequently, the name of the Company changed to Krishna Institute of Medical Sciences Private Limited on January 2, 2004 and further upon its conversion to a Public Company, the name was changed to Krishna Institute of Medical Sciences Limited on January 29, 2004. The Company is one of the largest corporate groups in India, with hospitals in Telangana, Andhra Pradesh Maharashtra providing multidisciplinary integrated services with a focus on tertiary and quaternary healthcare at affordable cost. It is engaged in rendering medical and healthcare services. It operate 12 multispecialty hospitals under the KIMS Hospitals brand, with an aggregate capacity of over 5000 beds. It offer a comprehensive range of healthcare services in over 40 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother child care.Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. In February 2003, acting in pursuance of the Takeover MoU, certain of its Promoters, namely Dr. Bhaskar Rao Bollineni, Krishnaiah Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company.Led by Dr. Bhaskar Rao Bollineni, Managing Director and CEO of the Company, a renowned cardiothoracic surgeon, it has grown from a single hospital to a chain of multispecialty hospitals, both organically and through strategic acquisitions. The oldest hospital in their network was established in 2000 at Nellore, by its Corporate Promoter, BRMH, with a capacity of approximately 200 beds and, At present, the hospital network has grown to six multispecialty hospitals in six cities, with a total capacity of 4000 beds, including 1,705 operational beds. The Hospitals are equipped with stateoftheart medical equipment and employ practices and policies which help to provide quality healthcare services to their patients. It was one of the first hospitals in Hyderabad to install 4Arm HD da Vinci Robot technology at Secunderabad hospital. The flagship hospitals at Secunderabad and Rajahmundry have been accredited by the National Accreditation Board for Hospitals and Healthcare Providers, India (NABH). The Hospital at Secunderabad is accredited with ISO 9001:2008 certification and has also been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL). The Hospital situated at Secunderabad was awarded the Healthcare Excellence Award, by the Indo Global Healthcare Summit and Expo, in 2015. It has also received awards from the Association of Healthcare Providers (India) (AHPI) for nursing excellence, in 2015 and for Patient Friendly Hospital, in 2017. In 2017, it was awarded the best hospital of the year in the multispecialty hospital category in Hyderabad by Times Healthcare Achievers Awards and in 2016 received the Pharmacie DeQualite certification from Bureau Veritas. Further, it was the first hospital in Andhra Pradesh and Telangana to have been Green OT certified in 2016. It is also the laureate of the Asia Pacific Society of Infection Control CSSD Center of Excellence Silver Award 20152016. Neurology India Journal has ranked the neurology department at its hospital at Secunderabad as the third biggest centre in India on the basis of volume of epilepsy surgeries performed, as on July 31, 2016.In addition to healthcare services, the company also conduct medical education programmes through its affiliations with state medical boards and universities, for various broad and super specialties at its hospitals in Secunderabad and Rajahmundry, including for DNB, under graduation, postgraduation, PhD and diploma programmes. It is also affiliated with Kaloji Narayana Rao University of Health Sciences and the Andhra Pradesh Para Medical Board.During 2022, Sunshine Hospitals became subsidiary of the Company effective from April, 2022. In 202223, the Company opened an exclusive Gastroenterology unit at Vizag. During FY 202223, Sarvejana Healthcare Private Limited became a Subsidiary of the Company effective 01st April 2022 SPANV Medisearch Lifesciences Private Limited became the Subsidiary of Company on 01.09.2022. Suryateja Healthcare Private Limited has ceased to be step down subsidiary of the Company w.e.f. December 01, 2022.The Nagpur Hospital became functional in 2024. The Company acquired a running hospital of 200 bedsQUEENS NRI HOSPITAL in Vizag, Andhra Pradesh in Jul24.The Company opened two units at Kannur and Kollam in Kerala in FY25. The first liver transplantation in Rayalaseema region in Andhra Pradesh took place in KIMS hospitals at Kurnool. Similarly, another liver transplantation took place at KIMS in Srikakulam in 2025. Company launched a 300bed facility in Thane, Mumbai in April 2025. Company operationalised fullfledged units in Nashik and Sangli (Maharashtra), Kannur and Kollam (Kerala) and Guntur (Andhra Pradesh). It launched the second unit, at Seethammadhara, with a fertility centre, Paediatric and Childcare unit under the Cuddles brand and a specialty care centre. It introduced a foot care clinic and a rehabilitation facility in Hyderabad.

    Krishna Institute of Medical Sciences Financial Highlights


    Krishna Institute of Medical Sciences reported a Q1 FY 2025-26 revenue of ₹871.6 crore, up 22.1% YoY, with net profit increased 23.3% to ₹85 crore. For the full year FY20252026, revenue reached ₹3067 crore and profit touched at ₹414.8 crore. As of Jun '25, Krishna Institute of Medical Sciences’s market capitalisation stood at ₹30,776.69 crores. Shareholding as of Jun '25 shows promoters holding 34.1%, with FIIs at 15.5%, DIIs at 31.7%, and public at 18.7%.

    As of 20 Aug, 2025, Krishna Institute of Medical Sciences share price is ₹771. The stock opened at ₹771 and had closed at ₹769.2 the previous day. During today’s trading session, Krishna Institute of Medical Sciences share price moved between ₹765.00 and ₹773.00, with an average price for the day of ₹769.00. Over the last 52 weeks, the stock has recorded a low of ₹461.63 and a high of ₹798.40. In terms of performance, Krishna Institute of Medical Sciences share price has increased by 43.5% over the past six months and has increased by 60.49% over the last year.
    Read More
    Krishna Institute of Medical Sciences SIP Return Calculator

    Over the past

    1 year
    3 years
    Total Investment of ₹65,00,000
    Would have become ₹89,37,243 (+37.50%)
    Daily SIP of 25,000 would have become 89,37,243 in 1 year with a gain of 24,37,243 (+37.50%)
    View details of Market Depth

    Krishna Institute of Medical Sciences Fundamental

    Market Cap (in crs)

    30,776.69

    Face Value

    2

    Turnover (in lacs)

    597.66

    Key Metrics

    Qtr Change %
    Near 52W High of ₹798.40
    19.5
    Dividend yield 1yr %
    0

    Krishna Institute of Medical Sciences Key Financials

    View more
    Loading chart...
    Loading chart...
    Loading chart...
    Loading chart...
    Krishna Institute of Medical Sciences Quarterly Revenue
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    871.6 Cr
    796.9 Cr
    772.4 Cr
    777.3 Cr
    688.4 Cr
    Krishna Institute of Medical Sciences Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    3067 Cr
    2511.2 Cr
    2223.55 Cr
    1671.08 Cr
    1340.1 Cr
    1128.73 Cr
    Krishna Institute of Medical Sciences Quarterly Net Profit/Loss
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    85 Cr
    106.1 Cr
    92.5 Cr
    120.7 Cr
    95.2 Cr
    Krishna Institute of Medical Sciences Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    414.8 Cr
    336.28 Cr
    365.81 Cr
    334.28 Cr
    205.48 Cr
    115.07 Cr

    Krishna Institute of Medical Sciences Result Highlights

    • Krishna Institute of Medical Sciences Ltd reported a 37.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 26.8%.

    • Its expenses for the quarter were up by 42.3% QoQ and 35.2% YoY.

    • The net profit increased 18.9% QoQ and decreased 10.7% YoY.

    • The earnings per share (EPS) of Krishna Institute of Medical Sciences Ltd stood at 2 during Q1 FY 2025-26.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Krishna Institute of Medical Sciences Shareholding Pattern

    Promoter
    34.1%
    Foreign Institutions
    15.5%
    Mutual Funds
    25.2%
    Domestic Institutions
    31.7%
    Public
    18.7%
    Promoter
    38.8%
    Foreign Institutions
    15.4%
    Mutual Funds
    25.4%
    Domestic Institutions
    32%
    Public
    13.8%
    Promoter
    38.8%
    Foreign Institutions
    15.7%
    Mutual Funds
    26%
    Domestic Institutions
    32%
    Public
    13.4%
    Promoter
    38.8%
    Foreign Institutions
    15.8%
    Mutual Funds
    25.8%
    Domestic Institutions
    32.3%
    Public
    13%
    Promoter
    38.8%
    Foreign Institutions
    17.8%
    Mutual Funds
    25.3%
    Domestic Institutions
    32.2%
    Public
    11.2%
    Promoter
    38.8%
    Foreign Institutions
    16.7%
    Mutual Funds
    26.3%
    Domestic Institutions
    33.2%
    Public
    11.3%

    Krishna Institute of Medical Sciences Technical Analysis

    Moving Averages Analysis
    769.65
    Current Price
    Bullish Moving Averages
    16
    Bearish Moving Averages
    0
    5Day EMA
    753.20
    10Day EMA
    747.70
    12Day EMA
    746.80
    20Day EMA
    742.30
    26Day EMA
    737.70
    50Day EMA
    717.70
    100Day EMA
    684.20
    200Day EMA
    634.20
    5Day SMA
    748.60
    10Day SMA
    741.80
    20Day SMA
    750.50
    30Day SMA
    742.10
    50Day SMA
    710.80
    100Day SMA
    678.60
    150Day SMA
    646.80
    200Day SMA
    633.20
    Delivery & Volume
    Loading chart...

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    154463 Rs
    296814 Rs
    Week Rs
    203431 Rs
    371082 Rs
    Month Rs
    399498 Rs
    676151 Rs
    764.23
    Pivot
    Resistance
    First Resistance
    776.32
    Second Resistance
    783.48
    Third Resistance
    795.57
    Support
    First Support
    757.07
    Second support
    744.98
    Third Support
    737.82
    Relative Strength Index
    60.50
    Money Flow Index
    40.24
    MACD
    9.11
    MACD Signal
    10.10
    Average True Range
    24.42
    Average Directional Index
    20.33
    Rate of Change (21)
    1.04
    Rate of Change (125)
    30.01
    Name
    Holding Percent
    Sbi Small Cap Fund
    6.02
    Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund A/C Axis Small Cap Fund
    5.24
    Hdfc Small Cap Fund
    4.38
    Kotak Small Cap Fund
    3.05
    Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund
    1.55
    Invesco India Flexi Cap Fund
    1.23
    Amansa Holdings Private Limited
    1.93
    Nomura India Investment Fund Mother Fund
    1.72
    Sbi Life Insurance Co. Ltd
    3.44
    Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110
    1.32
    Hdfc Life Insurance Company Limited
    1.05

    Krishna Institute of Medical Sciences Latest News

    13 AUG 2025 | Wednesday

    Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    11 AUG 2025 | Monday

    Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    09 AUG 2025 | Saturday

    Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    View More

    Krishna Institute of Medical Sciences Share Price FAQs

    Krishna Institute of Medical Sciences share price is ₹769.35 in NSE and ₹768.40 in BSE as on 20/8/2025.

    Krishna Institute of Medical Sciences share price in the past 1-year return was 62.18. The Krishna Institute of Medical Sciences share hit a 1-year low of Rs. 461.63 and a 1-year high of Rs. 798.4.

    The market cap of Krishna Institute of Medical Sciences is Rs. 30776.69 Cr. as of 20/8/2025.

    The PE ratios of Krishna Institute of Medical Sciences is 105.12 as of 20/8/2025.

    The PB ratios of Krishna Institute of Medical Sciences is 14.18 as of 20/8/2025

    The Mutual Fund Shareholding in Krishna Institute of Medical Sciences was 25.25% at the end of 20/8/2025.

    You can easily buy Krishna Institute of Medical Sciences shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Krishna Institute of Medical Sciences share price is ₹798.4 and ₹461.63 as of 20/8/2025.

    The earnings per share (EPS) of Krishna Institute of Medical Sciences stood at 2 during Q1 FY 2025-26.

    Please be aware that Krishna Institute of Medical Sciences stock prices are subject to continuous fluctuations due to various factors.

    Open Demat Account
    +91 -

    Popular Stocks
    59.47
    -0.12 (-0.20%)
    127.40
    +0.60 (+0.47%)
    691.10
    -9.15 (-1.31%)
    2,397.30
    +8.90 (+0.37%)
    149.00
    +0.09 (+0.06%)
    330.75
    +3.00 (+0.92%)
    161.83
    +2.60 (+1.63%)
    327.30
    +5.85 (+1.82%)
    375.35
    -4.70 (-1.24%)
    391.40
    +2.25 (+0.58%)
    Top Gainers
    1,479.90
    +39.90 (+2.77%)
    329.15
    +7.70 (+2.40%)
    2,649.00
    +44.20 (+1.70%)
    1,517.60
    +20.90 (+1.40%)
    3,058.30
    +42.10 (+1.40%)
    Top Losers
    615.15
    -11.20 (-1.79%)
    889.30
    -13.00 (-1.44%)
    690.65
    -9.60 (-1.37%)
    375.15
    -4.90 (-1.29%)
    5,449.00
    -47.00 (-0.86%)
    Open Demat Account
    +91 -